跳至主要内容
临床试验/NCT03101150
NCT03101150已完成1 期

Effect of Antenatal Vitamin D3 Supplementation on Risk of Pre-eclampsia

King Fahad Medical City0 个研究点目标入组 179 人开始时间: 2012年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
179
主要终点
Number of Participants With Pre-eclampsia in Both Arms

研究概览

简要总结

Vitamin D deficient pregnant ladies were selected and randomized into 2 groups for routine daily dose of multivitamin (400IU vitamin D3) versus maximum safest treatment daily dose (4000IU vitamin D3). Participants were assessed and compared for number of pre-eclampsia cases.

详细描述

Vitamin D3 has key role in decidualization and implantation of placenta.Vitamin D deficiency is thought to have positive association with pre-eclampsia.Vitamin D deficiency is highly prevalent in some parts of the world and it is not universally screened antenatally. Pre-eclampsia is a known multifactorial pregnancy disorder with significant maternal and perinatal morbidity and mortality. Vitamin D3 has a down-regulating effect on inflammatory pathways and reducing endothelial cell damage.

Investigators want to assess in vitamin D deficient group whether treatment reduces the risk of pre-eclampsia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Confirmed singleton pregnancy of less than 13 completed weeks of gestation at the time of consent.
  • Planned to receive antenatal care in King Fahad Medical City antenatal clinic.
  • The ability to provide written informed consent at the first visit.
  • Low risk pregnancy; and Serum vitamin D3 levels less than < 25nmol/L.

排除标准

  • Mothers with pregnancy with abnormal foetus.
  • Previous history of hypertension, pre-eclampsia, recurrent miscarriages.
  • Chronic kidney disease, chronic liver disease, and malignancy.

研究组 & 干预措施

400 IU Vitamin D3

Active Comparator

400IU vitamin D3 contained in antenatal multivitamin once daily by mouth starting from 14 weeks of pregnancy till delivery.

干预措施: 400 IU Vitamin D3 (Drug)

4000 IU Vitamin D3

Experimental

4000 IU Vitamin D3 drops once daily by mouth starting from 14 weeks of pregnancy till delivery.

干预措施: 4000 IU Vitamin D3 (Drug)

结局指标

主要结局

Number of Participants With Pre-eclampsia in Both Arms

时间窗: From 20 weeks of pregnancy till event of pre-eclampsia seen, whichever came first, assessed up to 32 weeks.

Occurrence of pre-eclampsia or not in all patients irrespective of Vitamin D dose.

次要结局

  • Change in Vitamin D Level(At 36th week of pregnancy)
  • Number of Patients With Intrauterine Growth Retardation(At delivery)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Aisha Mansoor Ali

Assistant Consultant Obstetric and Gynecology

King Fahad Medical City

相似试验

Effect of Vitamin D3 Supplementation in Pregnancy on... | 临床试验